Alliance Wealth Management Group Matinas Bio Pharma Holdings, Inc. Transaction History

Alliance Wealth Management Group

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$0.42 - $0.74 $168,346 - $296,611	-400,826 Closed	0 $0
Q4 2017 Jan 31, 2018	SELL	$1.1 - $1.54 $440,908 - $617,272	-400,826 Reduced 50.0%	400,826 $465,000
Q3 2017 Nov 09, 2017	BUY	$1.19 - $1.43 $953,965 - $1.15 Million	801,652	801,652 $1.06 Million

25.8M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $36.9M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Alliance Wealth Management Group, based on Form 13F filings with the SEC.

Stay updated on Alliance Wealth Management Group with notifications on news.